Missing data are a frequently encountered problem in epidemiologic and clinical research. 1, 2 One approach is to include in the analysis only those participants without missing observations (complete ...

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the presentation of data highlighting promising clinical activity of EVT801 in high ...

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025 Provided by Business Wire May 20, 2025, 12:26:00 PM ...

CAMBRIDGE, England & BOSTON, April 29, 2025--Bicycle Therapeutics plc (NASDAQ: BCYC), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary ...